Cargando…

Novel Strategies for the Treatment of COVID-19

On 4 September, 2020, the US National Institutes of Health launched a new clinical trial, “A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic and Additional Strategies in Hospitalized Adults with COVID-19.” This open-label, placebo-controlled,...

Descripción completa

Detalles Bibliográficos
Autor principal:	McCarthy, Matthew W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398904/ https://www.ncbi.nlm.nih.gov/pubmed/35999352 http://dx.doi.org/10.1007/s40268-022-00400-8

Ejemplares similares

The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
por: McCarthy, Cian P, et al.
Publicado: (2017)

eClinic: increasing use of telehealth as a risk reduction strategy during the covid-19 pandemic
por: Kemp, Michael T, et al.
Publicado: (2020)

Strategies to conserve salbutamol pressurized metered-dose inhaler stock levels amid COVID-19 drug shortage
por: Elbeddini, Ali, et al.
Publicado: (2020)

IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?
por: Atal, Shubham, et al.
Publicado: (2020)

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK
por: Jandu, Rajmeet, et al.
Publicado: (2022)

Beyond COVID-19 deaths during the COVID-19 pandemic in the United States
por: Jacobson, Sheldon H., et al.
Publicado: (2021)

Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?
por: Edan, Gilles, et al.
Publicado: (2023)

Assessing the Safety of COVID-19 Vaccines: A Primer
por: Petousis-Harris, Helen
Publicado: (2020)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Optimizing the trauma resuscitation bay during the covid-19 pandemic
por: Livingston, David Hugh, et al.
Publicado: (2020)

Resuming elective surgical services in times of COVID-19 infection
por: Coimbra, Raul, et al.
Publicado: (2020)

Strategies to Reduce Errors Associated with 2-Component Vaccines
por: Samad, Farzana, et al.
Publicado: (2020)

Approval of Itolizumab for COVID-19: A Premature Decision or Need of The Hour?
por: Atal, Shubham, et al.
Publicado: (2020)

Paradigm shift of drug information centers during the COVID-19 pandemic
por: Khatiwada, Asmita Priyadarshini, et al.
Publicado: (2020)

Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19
por: Khan, Sikandar Hayat, et al.
Publicado: (2020)

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
por: Torres, Tiago, et al.
Publicado: (2020)

Recommendations for Face Coverings While Exercising During the COVID-19 Pandemic
por: Shurlock, Jonathan, et al.
Publicado: (2021)

Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
por: Charpiat, Bruno, et al.
Publicado: (2020)

Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines
por: Sultana, Janet, et al.
Publicado: (2020)

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
por: Hum, Christine, et al.
Publicado: (2021)

Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
por: Bianconi, Vanessa, et al.
Publicado: (2020)

The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets
por: Casucci, Gerardo, et al.
Publicado: (2020)

Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview
por: Parreiras Martins, Maria Auxiliadora, et al.
Publicado: (2020)

Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide
por: Kow, Chia Siang, et al.
Publicado: (2020)

The G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19
por: Panera, Nadia, et al.
Publicado: (2020)

Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems
por: Shrestha, Sunil, et al.
Publicado: (2021)

Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic
por: Ghosh, Romik, et al.
Publicado: (2021)

Safety of International Professional Sports Competitions During the COVID-19 Pandemic: The Association Football Experience
por: Caniza, Horacio, et al.
Publicado: (2022)

Excess deaths by sex and Age Group in the first two years of the COVID-19 pandemic in the United States
por: Ludden, Ian G., et al.
Publicado: (2022)

Pharmacotherapeutic considerations for systemic rheumatic diseases amid the COVID-19 pandemic: more questions than answers
por: Kow, Chia Siang, et al.
Publicado: (2020)

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
por: Zheng, Crystal, et al.
Publicado: (2020)

Can mRNA Vaccines Turn the Tables During the COVID-19 Pandemic? Current Status and Challenges
por: Sagili Anthony, Deva Priya, et al.
Publicado: (2021)

Treating Acute Decompensated Heart Failure in Patients with COVID-19 Using Intravenous Nitroglycerin in 5% Glutathione
por: Kaesemeyer, Wayne, et al.
Publicado: (2021)

Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond
por: Furtner, Daniel, et al.
Publicado: (2021)

Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
por: Bauchau, Vincent, et al.
Publicado: (2023)

Towards a more efficient healthcare system: Opportunities and challenges caused by hospital closures amid the COVID-19 pandemic
por: Saghafian, Soroush, et al.
Publicado: (2022)

Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
por: Plocque, Alexia, et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
por: Chalkias, Athanasios, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tcceqqp7ust3umrn206cbsb5p3